The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Somatic mutation profiling of advanced breast and ovarian cancers according to germline BRCA1/2 mutation status.
 
Neda Stjepanovic
No Relationships to Disclose
 
Michelle K. Wilson
Consulting or Advisory Role - AstraZeneca
 
Amit M. Oza
Consulting or Advisory Role - Amgen; Clovis Oncology; Verastem
Research Funding - AstraZeneca; Immunogen; Immunovaccine; Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Blaise Clarke
No Relationships to Disclose
 
Hal K. Berman
No Relationships to Disclose
 
Eitan Amir
No Relationships to Disclose
 
Helen Mackay
No Relationships to Disclose
 
Patricia Shaw
Honoraria - AstraZeneca
 
Marcus O. Butler
Honoraria - Merck; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis
Expert Testimony - Merck
 
Anna Marie Mulligan
No Relationships to Disclose
 
Anca Milea
No Relationships to Disclose
 
Lailah Ahmed
No Relationships to Disclose
 
Alexandra Volenik
No Relationships to Disclose
 
Lisa Wang
No Relationships to Disclose
 
Trevor John Pugh
No Relationships to Disclose
 
Tracy Stockley
No Relationships to Disclose
 
Raymond H Kim
No Relationships to Disclose
 
Lillian L. Siu
Leadership - Agios (I)
Stock and Other Ownership Interests - Agios (I); Entremed (I)
Consulting or Advisory Role - Boehringer Ingelheim; Daiichi Sankyo; Merck; Novartis (Inst); Oncoethix
Research Funding - Abraxis BioScience; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Celgene; Genentech/Roche; GlaxoSmithKline; Karyopharm Therapeutics; MedImmune; Merck; Novartis; Pfizer; Regeneron
 
Suzanne Kamel-Reid
No Relationships to Disclose
 
Philippe L. Bedard
Consulting or Advisory Role - Genentech/Roche (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Oncothyreon (Inst); Sanofi (Inst); SERVIER (Inst); SignalChem (Inst)